Auryx builds a software platform that analyzes acoustic signals from the heart, lungs, and blood flow using microphones embedded in everyday consumer hardware. The company’s approach focuses initially on earbuds, leveraging the relative stability of the ear to capture cleaner physiological signals than wrist-based optical sensors. Auryx’s acoustic sensing can extract metrics beyond heart rate, including respiratory rate, cardiac output, and blood pressure according to the company. The founding team comprises researchers from the University of Cambridge, including CEO Erika Bondareva, CTO Kayla-Jade Butkow, and Chief Scientific Officer Professor Cecilia Mascolo. Auryx recently raised $2 million in pre-seed funding to accelerate hardware integration, model development, commercial partnerships, and team expansion. The company plans to expand from earbuds to other microphone-equipped devices and additional health applications.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Apr 2026